The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 11, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Monday, December 14, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Wednesday, December 30, 2020
The FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia.
read more
Ampio announced an update on the launch of a new global clinical trial for IV treatment of COVID-19 with Ampion.
read more
Tuesday, January 12, 2021
Radius Health has entered into definitive agreements with Endo Ventures Limited to register, commercialize, and distribute abaloparatide on an ...
read more
Theranica announced its Nerivio therapeutic device has received the FDA clearance to market for an expanded indication for acute treatment of episodic...
read more
Tuesday, January 26, 2021
Oramed announced randomization of patients in its first Phase 3 study of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes is ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Monday, February 01, 2021
Chiesi announced the European Commission has granted the marketing authorization for Chiesi extrafine triple therapy combination ICS/LABA/LAMA in a ...
read more
Thursday, February 04, 2021
Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies.
read more
Thursday, February 04, 2021
Logan’s Permeation-Barrier Membrane (PB-M) is a cellulose membrane.
read more
Wednesday, February 10, 2021
PaxMedica announced positive topline data from its trial PAX-101 as a potential treatment for the core symptoms of Autism.
read more
Friday, February 12, 2021
Pfizer and BioNTech announced the U.S. government has exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine...
read more
Friday, February 12, 2021
The FDA has informed Mallinckrodt it is deferring action on the Stratatech BLA for StrataGraft.
read more
Friday, February 12, 2021
Moderna announced the Canadian Government has increased its confirmed order commitment by 4 million doses of the COVID-19 Vaccine Moderna.
read more